Construction of Eukaryotic Expression Vector Pires2-Egfp-v13kl and Its Expression in COS-7 Cells and Mouse Embryos

GUAN Ji-yu,LI Song-li,ZHANG Peng,SONG Guang-qi,LIU Li-mei,LIU Ying,WANG Zhong-wei,GAO Fei,TANG Bo,CHEN Yu-xin,YUE Zhan-peng,LI Zi-yi
DOI: https://doi.org/10.16303/j.cnki.1005-4545.2011.04.006
2011-01-01
Abstract:The V13KL is a kind of antimicrobial peptides through optimal design and artificial synthesis,which it is characteristic of stronger antimicrobial activity and weaker hemolytic activity.This study was conducted to examine expression of this peptide in COS-7 cells and detect the effect of this peptide on early development of mouse embryos.The eukaryotic expression vector pIRES2-EGFP-V13KL was constructed,and transfected into the COS-7 cells and injected into the pronucleus of the mouse embryos.The results showed that V13KL and EGFP could co-express in COS-7 cells,and the transfection efficiency is 75.8%.About 10% of the mouse embryos injected with the vector developed into blastula.This study may be the basis of large-scale application and the cultivation of transgenic animals in the future.
What problem does this paper attempt to address?